When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ANAB - AnaptysBio up 2% on positive etokimab data in severe asthma
AnaptysBio Inc.
Thinly traded AnaptysBio (ANAB+2.3%) is up on below-average volume on the heels of updated results from a proof-of-concept Phase 2b clinical trial evaluating a single intravenous dose of lead candidate etokimab in 25 adults with severe eosinophilic asthma. The data were presented at EAACI in Lisbon, Portugal.
More news on: AnaptysBio, Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Stocks on the move,